Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis
Head & Neck · 2025
DOI: 10.1002/hed.70140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Rohan Vuppala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Georgia, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Immunotherapy. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
We evaluated the association between immunotherapy (IO) and overall survival (OS) in advanced head and neck squamous cell carcinoma (HNSCC) and examined outcomes by IO timing.
Methods
Retrospective cohort study of national NCDB 2004–2022 United States adults with Stages III–IVB HNSCC. Exposure was any IO. The primary outcome was OS from diagnosis; analyses used multivariable Cox models, 24‐month landmarking, and propensity methods.
Results
Among 221 116 patients (mean age: 62), 10 023 (4.5%) received IO. Median follow‐up 37 months. IO was associated with lower mortality (HR: 0.91; 95% CI: 0.89–0.94). Landmark analysis showed benefit 0–24 months (HR: 0.76; 0.74–0.79) that reversed thereafter (HR: 1.09; 1.04–1.14). By intent, median OS was 53.2 months (neoadjuvant), 50.1 months (adjuvant), 16.5 months (later‐line), versus 60.7 months without IO. Propensity analyses attenuated effects (HR: ~1.00).
Conclusions
In real‐world advanced HNSCC, IO confers modest early benefit with varied long‐term results; outcomes vary by timing. Prospective biomarker‐stratified trials are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical College of Georgia, Augusta, Georgia, USA.
- Department of Otolaryngology-Head and Neck Surgery, Medical College of Georgia, Augusta, Georgia, USA.
ORCID-Profile: Rohan Vuppala
Zitieren
APA
Vuppala, R., Long, S., Sharbel, D., & Weir, F. (2025). Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis. Head & Neck. https://doi.org/10.1002/hed.70140
Vancouver
Vuppala R, Long S, Sharbel D, Weir F. Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis. Head & Neck. 2025. doi:10.1002/hed.70140
BibTeX
@article{Vuppala2025,
author = {Vuppala, Rohan and Long, Sallie and Sharbel, Daniel and Weir, Forest},
title = {Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.70140}
}
EUVIMED